Proffitt & Goodson’s Labcorp LH Stock Holding History

Proffitt & Goodson’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3	Closed	-$862	–	380
2025 Q3	$862	Buy	+3	New	+$804	﹤0.01%	387

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Proffitt & Goodson's LH Position: Q4 2025 in Review

Proffitt & Goodson sold out of Labcorp (LH) in Q4 2025, closing a stake of 3 shares — an estimated $862 sold.

Proffitt & Goodson first reported a position in LH in Q3 2025 and held it in 1 quarter. The position peaked at $862 in Q3 2025. 1,029 funds tracked by Wall St. Rank hold LH as of Q4 2025.

Proffitt & Goodson reported no remaining Labcorp position as of Q4 2025 after selling out during the quarter.
Proffitt & Goodson sold 3 Labcorp shares in Q4 2025, an estimated $862.
Proffitt & Goodson first reported a position in Labcorp in Q3 2025 and held it in 1 quarter.
Proffitt & Goodson's Labcorp position peaked at $862 in Q3 2025.
1,029 funds tracked by Wall St. Rank held Labcorp as of Q4 2025.

Based on Proffitt & Goodson's 13F filing for Q4 2025, filed 27 Jan 2026.